Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β

Journal of Rheumatology

Volumn 24, Issue 7, 1997, Pages 1253-1259

  Jackson, Jeffrey R ^a,d   Minton, Jayne A L ^b   Ho, Maureen ^a   Wei, Nathan ^c   Winkler, James D ^a  

^a Department of Pulmonary Pharmacology   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Arthr Osteoporosis Ctr of Maryland   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Angiogenesis; Fibroblasts; Hypoxia; Interleukin 1 ; Rheumatoid arthritis; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 1BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ALTERNATIVE SPLICING; ARTHRITIS, RHEUMATOID; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030809469     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Colville-Nash PR, Scott DL: Angiogenesis and rheumatoid arthritis: Pathogeneic and therapeutic implications. Ann Rheum Dis 1992;51:919-25.
2. Folkman J, Brem H: Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates, 2nd ed. New York: Raven Press, 1992:821-39.
3. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-4.
4. Colville-Nash PR, Seed MP: The current state of angiostatic therapy, with special reference to rheumatoid arthritis. Curr Opin Invest Drugs 1993;2:763-813.
5. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995;1:27-31.
6. Koch AE, Polverini PJ, Leibovich JL: Induction of neovascularization by activated human monocytes. J Leuk Biol 1986;39:233-8.
7. Knighton DR, Hunt TK, Scheuenstuhl H, et al: Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283-5.
8. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leuk Biol 1994;55:410-22.
9. Ben-Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
10. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
11. Koch AE, Harlow LA, Haines GK, et al: Vascular endothelial growth factor a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
12. Fava RA, Olsen NJ, Spencer-Green G, et al: Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-6.
13. Nagashima M, Yoshino S, Ishiwata T, Asano G: Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995;22:1624-30.
14. Namiki A, Brogi E, Kearney M, et al: Hypoxia induces vascular endothelial growth factor in cultured human endothelial-cells. J Biol Chem 1995;270:31189-95.
15. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth-factor expression by hypoxia and by glucose deficiency in multicell spheroids - Implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-72.
16. Stevens CR, Williams RB, Farrell AJ, Blake DR: Hypoxia and inflammatory synovitis: Observations and speculation. Ann Rheum Dis 1991;50:124-32.
17. BenEzra D: Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthal 1978;86:455-61.
18. Motro B, Itin A, Sachs L, Keshet E: Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 1990;87:3092-6.
19. 2. J Rheumatol 1996;23:420-7.
20. Dayer J-M, Krane SM, Russell RGG, Robinson DR: Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci USA 1976;73:945-9.
21. Wilkinson LS, Pitsillides AA, Worrall JG, Edwards JCW: Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum 1992;35:1179-84.
22. Ben-Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
23. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41.
24. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-6.
25. Li J, Perrella MA, Tsai J-C, et al: Induction of vascular endothelial growth factor gene expression by interleukin-1ß in rat aortic smooth muscle cells. J Biol Chem 1995;270:308-12.
26. Shweiki D, Ahuva I, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
27. Jackson JR: Angiogenesis and inflammation. Pharmacol Rev Comm 1996;8:81-6.
28. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996;271:603-6.
29. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994;5:89-97.
30. Appleton I, Brown NJ, Willis D, et al: The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol 1996;180:90-4.
31. Edmonds SE, Blake DR, Morris CJ, Winyard PG: An imaginative approach to synovitis - the role of hypoxic reperfusion damage in arthritis. J Rheumatol 1993;(suppl 37)20:26-31.
32. BenEzra D, Hemo I, Maftzir G: In vivo angiogeneic activity of interleukins. Arch Ophthalmol 1990;108:573-6.
33. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin-6 induces the expression of vascular endothelial growth-factor. J Biol Chem 1996;271:736-41.
34. Rathanaswami P, Hachicha M, Wong WL, Schall TJ, McColl SR: Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum 1993;36:1295-304.
35. Abruzzo LV, Thornton AJ, Liebert M, et al: Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol 1992;140:365-73.
36. Kyriakis JM, Avruch J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313-6.
37. Rupec RA, Baeuerle PA: The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB. Ear J Biochem 1995;234:632-40.
38. Pelletier J-P, DiBatista JA, Roughly P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993;19:545-68.
39. Dieppe P: Osteoarthritis: The scale and scope of the clinical problem. In: Russell RGG, Dieppe P, eds. Osteoarthritis: Current Research and Prospects for Pharmacological Intervention. London: IBC Technical Services Ltd., 1991:4-23.